Co-Authors
This is a "connection" page, showing publications co-authored by DONNA M WEBER and CHARLES CLEELAND.
Connection Strength
0.094
-
Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma. Ann Hematol. 2017 Jun; 96(6):977-985.
Score: 0.038
-
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial. Blood Cancer J. 2016 Feb 12; 6:e396.
Score: 0.035
-
Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer. 2008 Apr 01; 112(7):1617-24.
Score: 0.021